140 related articles for article (PubMed ID: 1808964)
1. [Cytophotometric studies for evaluating the prognosis in endometrial cancer].
Köhler U; Krug H; Taubert G
Zentralbl Gynakol; 1991; 113(24):1371-9. PubMed ID: 1808964
[TBL] [Abstract][Full Text] [Related]
2. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
3. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
[TBL] [Abstract][Full Text] [Related]
4. [Morphologic studies of endometrial cancer for biological assessment of nuclear grading].
Köhler U
Zentralbl Gynakol; 1991; 113(18):995-1003. PubMed ID: 1750299
[TBL] [Abstract][Full Text] [Related]
5. The relation between the results of cytophotometric examination of endometrial carcinoma and clinical course of these disease.
Köhler U; Taubert G; Bilek K; Nenning A
Arch Gynecol Obstet; 1992; 252(2):93-7. PubMed ID: 1471917
[TBL] [Abstract][Full Text] [Related]
6. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of DNA ploidy in endometrial cancer.
Ikeda M; Watanabe Y; Nanjoh T; Noda K
Gynecol Oncol; 1993 Jul; 50(1):25-9. PubMed ID: 8349160
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
[TBL] [Abstract][Full Text] [Related]
11. [Variability of quantitative DNA parameters in endometrial carcinoma].
Köhler U; Naumann G; Nenning A; Taubert G; Bilek K
Zentralbl Gynakol; 1994; 116(11):609-13. PubMed ID: 7871910
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II.
Wagenius G; Bergström R; Strang P; Gerdes U; Rogo K; Tribukait B; Stendahl U
Anticancer Res; 1992; 12(3):725-32. PubMed ID: 1622130
[TBL] [Abstract][Full Text] [Related]
14. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
15. [Image analysis of DNA cytometry for assessing prognosis after resection of esophageal cancer].
Böttger T; Störkel S; Stöckle M; Wahl W; Heintz A; Jugenheimer M; Effenberger-Kim O; Vinh T; Junginger T
Chirurg; 1991 Jun; 62(6):467-72; discussion 472-3. PubMed ID: 1655366
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA; Ashfaq R; Albores-Saavedra J; Tavassoli FA
Cancer; 1997 May; 79(10):1933-43. PubMed ID: 9149020
[TBL] [Abstract][Full Text] [Related]
17. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens.
Pradhan M; Abeler VM; Davidson B; Kildal W; Nybøen A; Tropé CG; Risberg B; Danielsen HE
Int J Gynecol Pathol; 2010 Nov; 29(6):572-8. PubMed ID: 20881853
[TBL] [Abstract][Full Text] [Related]
19. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
Goodman A; Bell DA; Rice LW
Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
